Nicotinamide adenine dinucleotide, a coenzyme critical for cellular energy metabolism that declines with age. NAD+ precursors like NMN and NR are studied as longevity interventions.

Mechanistic target of rapamycin, a key nutrient-sensing pathway that regulates cell growth and aging. Inhibiting mTOR (e.g., with rapamycin) has shown lifespan extension in multiple organisms.

A class of drugs that selectively eliminate senescent (aged, dysfunctional) cells to reduce inflammation and improve tissue function.

What is Epigenetic clock?

A biomarker based on DNA methylation patterns that estimates biological age, often more predictive of health outcomes than chronological age.

The period of life spent in good health, free from chronic diseases and disability associated with aging.

An immunosuppressant drug that inhibits the mTOR pathway. Research shows rapamycin may extend lifespan and improve age-related health outcomes in multiple species.

What is Biological age?

A measure of how well or poorly your body is functioning relative to your chronological age, assessed through biomarkers such as DNA methylation, telomere length, and blood panels.

What is Caloric restriction?

A dietary regimen that reduces calorie intake without malnutrition. Caloric restriction is one of the most studied interventions shown to extend lifespan across species.

Protective caps at the ends of chromosomes that shorten with each cell division. Telomere length is associated with aging and age-related diseases.

A state in which cells permanently stop dividing but resist death, accumulating with age and secreting inflammatory factors that damage surrounding tissue.

A second-generation epigenetic clock that predicts time to death and is considered one of the most accurate measures of biological aging.

What is Inflammaging?

Chronic, low-grade inflammation that increases with age and contributes to the development of age-related diseases including cardiovascular disease, diabetes, and neurodegeneration.

The large-scale study of proteins in biological systems. In longevity research, proteomics identifies blood protein signatures that predict biological age and disease risk.

What is Yamanaka factors?

A set of four transcription factors (Oct4, Sox2, Klf4, c-Myc) that can reprogram adult cells to a pluripotent state. Partial reprogramming with Yamanaka factors is being explored to reverse cellular aging.

Nicotinamide mononucleotide, a precursor to NAD+ that is widely studied as a supplement to boost cellular energy and combat age-related decline.

A gene-editing technology that allows precise modifications to DNA. In longevity research, CRISPR is used to study and potentially modify genes associated with aging.

A cellular housekeeping process where cells break down and recycle damaged components. Declines with age and is stimulated by fasting.

What is Intermittent fasting?

An eating pattern that cycles between periods of fasting and eating. Various protocols (16:8, 5:2) are studied for metabolic, cardiovascular, and longevity benefits.

What is Zone 2 cardio?

Low-intensity aerobic exercise performed at roughly 60–70% of maximum heart rate, primarily using the aerobic energy system. Associated with mitochondrial health and longevity.

Geographic regions identified by researchers where people consistently live longer and healthier lives than average, including Sardinia, Okinawa, and Loma Linda.

All Articles

Browse all articles — filter by topic, how strong the science is, or date.

May 15, 2026 globenewswire.com

Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence

Background Industry & Access

Apr 28, 2026 longevity.technology

Bioxodes to present final Phase 2a trial results confirming breakthrough potential of BIOX-101 for intracerebral hemorrhage in poster at ESOC 2026

Background Industry & Access

Apr 28, 2026 globenewswire.com

Boehringer Ingelheim’s novel glucagon/GLP-1 dual agonist survodutide achieved significant weight loss of 16.6% delivering meaningful metabolic improvement in people with obesity or overweight in Phase III trial

Background Treatments & Drugs

Apr 28, 2026 sciencedaily.com

Biomea Fusion Announces Positive 52-Week Results from Phase 2 COVALENT-112 Trial in Type 1 Diabetes Showing C-Peptide Improvement and Durability Following 12-Weeks of Icovamenib Treatment

Background Treatments & Drugs

Apr 27, 2026 globenewswire.com

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

Background Measuring Aging

Apr 27, 2026 globenewswire.com

Arbor Biotechnologies to Present Expansion of CNS Editing Platform Capabilities at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting

Background Science & Tech

Apr 27, 2026 globenewswire.com

Dyne Therapeutics Announces Upcoming Presentation Highlighting Robust CNS Activity in Nonhuman Primates with its FORCE™ Platform at 2026 ASGCT Annual Meeting

Background Science & Tech

Apr 27, 2026 globenewswire.com

Umoja Biopharma Announces Unveiling of UB-VV500 in Upcoming Poster Presentation at the American Society of Gene & Cell Therapy Annual Meeting

Background Treatments & Drugs

Apr 27, 2026 globenewswire.com

Australian Patent Granted to NurExone Covering Stem Cell-Derived Exosome Production

Background Industry & Access

Apr 27, 2026 globenewswire.com

Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors

Background

Apr 27, 2026 globenewswire.com

Aegis Treatment Centers Opens Medication Unit in Crescent City, Expanding Access to Addiction Treatment in Del Norte County

Background Treatments & Drugs

Apr 27, 2026 fightaging.org

Does Exposure to Air Pollution Literally Accelerate Aging?

Important Measuring Aging

Apr 27, 2026 globenewswire.com

AI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation

Background Science & Tech

Apr 27, 2026 longevity.technology

University of New England launches new Institute of Public and Planetary Health in honor of philanthropist and IDEXX Founder David Evans Shaw

Background

Apr 27, 2026 sciencedaily.com

Backed by Goldman Sachs, Urgent Care Provider Xpress Wellness Appoints New Chief Operating Officer to Support Continued Growth

Background

Apr 27, 2026 globenewswire.com

WellSpan Behavioral Health Walk-In Crisis Center opens in York

Background Industry & Access

Apr 27, 2026 globenewswire.com

Alpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer Studies

Background Measuring Aging

Apr 27, 2026 globenewswire.com

MS Canada Calls on Canadians to Take Action During MS Awareness Month Towards a World Free of MS

Background

Apr 27, 2026 globenewswire.com

Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program

Background Treatments & Drugs

Apr 27, 2026 sciencedaily.com

Scientists may have found the brain’s switch for chronic pain

Background

Apr 27, 2026 globenewswire.com

Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2-Associated ARVC at ASGCT 2026

Background Science & Tech

Apr 27, 2026 globenewswire.com

MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling

Background Industry & Access

Apr 27, 2026 globenewswire.com

Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015

Background Food & Lifestyle

Apr 27, 2026 globenewswire.com

Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty

Background Industry & Access

Apr 27, 2026 globenewswire.com

PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01

Background Industry & Access

Apr 27, 2026 globenewswire.com

Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% to Expand Indication for Treatment of Atopic Dermatitis to Infants Down to 3 Months

Background Food & Lifestyle

Apr 27, 2026 globenewswire.com

Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer

Background

Apr 27, 2026 globenewswire.com

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

Background Industry & Access

Apr 27, 2026 globenewswire.com

HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors

Background Industry & Access

Apr 27, 2026 globenewswire.com

Alterity Therapeutics Receives Positive FDA Feedback Following Second Type C Meeting on ATH434 Phase 3 Program in Multiple System Atrophy

Background Industry & Access

Apr 27, 2026 globenewswire.com

Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis

Background

Apr 27, 2026 globenewswire.com

Ocular Therapeutix™ to Participate in May Scientific and Investor Conferences

Background Treatments & Drugs

Apr 27, 2026 globenewswire.com

Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing

Background Science & Tech

Apr 27, 2026 globenewswire.com

Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema

Background Science & Tech

Apr 27, 2026 globenewswire.com

Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer

Background Treatments & Drugs

Apr 27, 2026 globenewswire.com

Heat-related deaths in social care in England: can the Care Quality Commission ratings system be used to identify care homes that would benefit most from heat adaptation measures?

Background Food & Lifestyle

Apr 26, 2026 globenewswire.com

Study Shows Implicity’s New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern Devices

Background

Apr 25, 2026 globenewswire.com

KFSH Expande a Medicina Genômica da Pesquisa para a Tomada de Decisão Clínica

Background Food & Lifestyle

Apr 25, 2026 globenewswire.com

KFSH amplía la medicina genómica desde la investigación hasta la toma de decisiones clínicas

Background

Apr 24, 2026 globenewswire.com

Intellia Therapeutics to Report Topline Data from Global Phase 3 HAELO Clinical Trial of Lonvoguran Ziclumeran in Hereditary Angioedema on April 27, 2026

Background Science & Tech

Apr 24, 2026 globenewswire.com

Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder

Background Treatments & Drugs

Apr 24, 2026 globenewswire.com

DNA DAY™ 2026: GeneLife Advances GeneAI Forecast with 15 Predictive Models and Enhanced Lifestyle Integration

Background Science & Tech

Apr 24, 2026 globenewswire.com

Medicana Health Group Launches HPV Vaccination and Cervical Cancer Awareness Campaign, Advancing Prevention Through Regular Check-Ups

Background

Apr 24, 2026 globenewswire.com

Gain Therapeutics Announces Oral Presentation at 3rd International GBA1 Meeting 2026

Background Measuring Aging

Apr 24, 2026 globenewswire.com

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

Background Industry & Access

Apr 24, 2026 globenewswire.com

Dogecoin Cash, Inc. Highlights Telehealth Platform Strategy Following Federal Actions Relating to Marijuana Reclassification

Background

Apr 24, 2026 fightaging.org

Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program

Background Measuring Aging

Apr 24, 2026 globenewswire.com

Tissue Engineering Market to Grow at 12.95% CAGR Reaching USD 27.59 Billion by 2031, Driven by Advances in Regenerative Medicine and Biomaterials, Says Mordor Intelligence

Background Industry & Access

Apr 24, 2026 longevity.technology

Regeneron Announces Agreement with U.S. Government to Help Lower Drug Costs for American Patients and Will Provide Innovative New Gene Therapy for Free in the U.S.

Background Science & Tech

Apr 23, 2026 globenewswire.com

This Alcohol Awareness Month, Oxford Treatment Center Raises Red Flag, Citing Significant Rise in Patients Seeking Help for Alcohol Addiction

Background Food & Lifestyle

Apr 23, 2026 globenewswire.com

Cook County Health Recognizes 60th Anniversary of Trauma Unit

Background Food & Lifestyle

Apr 23, 2026 globenewswire.com

AI-Powered Nerve Monitoring Systems Poised to Transform Surgical Safety as Workforce Shortages Drive Remote Monitoring Adoption

Background Science & Tech

Apr 23, 2026 fightaging.org

PridCor Therapeutics Secures Global Antiviral Portfolio, Establishing Leadership in Treatment of Long COVID and Infection-Associated Chronic Illnesses

Background Industry & Access

Apr 23, 2026 globenewswire.com

IMAAVY® (nipocalimab)▼shows over two years of sustained disease control in a broad population with generalised myasthenia gravis (gMG)

Background Industry & Access

Apr 23, 2026 globenewswire.com

The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic

Background Treatments & Drugs

Apr 23, 2026 globenewswire.com

Lumina Therapy Alliance Expands Silicon Valley Presence with Addition of Wise Mind Institute in Redwood City, CA

Background Science & Tech

Apr 23, 2026 globenewswire.com

InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability

Background Industry & Access

Apr 23, 2026 globenewswire.com

Leading Kidney Organizations Unite on Capitol Hill for “Kidney Diseases: The Hidden Crisis in American Health Care” Congressional Briefing

Background

Apr 23, 2026 globenewswire.com

Alpha Tau Announces FDA Approval of IDE Supplement to Expand Alpha DaRT® IMPACT Trial to Patients with Pancreatic Cancer Receiving Gemcitabine with Abraxane® (Nab-Paclitaxel)

Background Measuring Aging

Apr 23, 2026 globenewswire.com

Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Europe with Alpha DaRT® in French Multicenter ACAPELLA Clinical Trial

Background Measuring Aging

Apr 23, 2026 globenewswire.com

Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction

Background

Apr 23, 2026 globenewswire.com

NEW YORK PLASTIC SURGICAL GROUP ANNOUNCES OPENING OF HARRISON, NY LOCATION

Background Food & Lifestyle

Apr 23, 2026 globenewswire.com

Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M

Background Industry & Access

Apr 23, 2026 globenewswire.com

Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis

Background

Apr 23, 2026 globenewswire.com

Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026

Background

Apr 23, 2026 globenewswire.com

Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications

Background Industry & Access

Apr 23, 2026 globenewswire.com

Nanox Signs Distribution Agreement with Radiology Oncology Systems to Expand Nanox.ARC Adoption in the United States

Background

Apr 23, 2026 globenewswire.com

MBX Biosciences to Host In-Person and Virtual Obesity Day on May 11, 2026 to Discuss Expanding Obesity Portfolio

Background Industry & Access

Apr 23, 2026 globenewswire.com

electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation

Background Food & Lifestyle

Apr 23, 2026 sciencedaily.com

These 80-year-olds have the memory of 50-year-olds. Scientists now know why

Important Measuring Aging

Apr 23, 2026 globenewswire.com

Transcenta Therapeutics Presents New Data for its Novel LIV1-Targeting ADC TST013 Demonstrating Potent Anti-Tumor Activity in PDX Models of Prostate Cancer and ER Positive /HER2 Negative Breast Cancer

Background Food & Lifestyle

Apr 23, 2026 globenewswire.com

Tonix Pharmaceuticals Presents Updates on Preclinical Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2026

Background Treatments & Drugs

Apr 23, 2026 globenewswire.com

Une découverte susceptible de valoir un prix Nobel par les scientifiques de VectorBuilder révèle les mécanismes fondamentaux du développement

Background Measuring Aging

Apr 23, 2026 globenewswire.com

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

Background Treatments & Drugs

Apr 22, 2026 globenewswire.com

George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage

Background Measuring Aging

Apr 22, 2026 globenewswire.com

BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026

Background Treatments & Drugs

Apr 22, 2026 globenewswire.com

Abivax to Present Data on Obefazimod at Digestive Disease Week®

Background Industry & Access

Apr 22, 2026 globenewswire.com

Canadian Association of Occupational Therapy Calls for Expansion of Canada Student Loan Forgiveness Program to Include Occupational Therapy

Background

Apr 22, 2026 globenewswire.com

MedShop Direct Expands White Glove Delivery and Installation of Adjustable Medical Beds for Assisted Living and Home Care Across 48 States

Background Industry & Access

Apr 22, 2026 lifespan.io

The Immune System Ages Differently in Men and Women

Important Science & Tech

Apr 22, 2026 globenewswire.com

Providence Saint John’s Study Finds Lifestyle Program Improves Brain Health in Patients with Early Cognitive Impairment

Background Measuring Aging

Apr 22, 2026 globenewswire.com

Columbia University Fertility Center, Weill Cornell Medicine, and NYU Langone Fertility Center Named Among America’s Best Fertility Clinics 2026 by Newsweek

Background

Apr 22, 2026 globenewswire.com

Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial

Background Industry & Access

Apr 22, 2026 sciencedaily.com

Hidden virus in your gut may be linked to colon cancer

Important Food & Lifestyle

Apr 22, 2026 globenewswire.com

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

Background Industry & Access

Apr 22, 2026 globenewswire.com

Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting

Background Treatments & Drugs

Apr 22, 2026 globenewswire.com

Amae Health and Novant Health bring enhanced integrated care model for severe mental illness to Charlotte, North Carolina

Background Industry & Access

Apr 22, 2026 globenewswire.com

Agora and thymia Partner to Enable Real-Time Health and Safety Intelligence Across Voice Communications

Background Science & Tech

Apr 22, 2026 sciencedaily.com

A simple blood test could reveal Alzheimer’s risk years early

Important Measuring Aging

Apr 22, 2026 globenewswire.com

Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®

Background Food & Lifestyle

Apr 22, 2026 globenewswire.com

CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026

Background Measuring Aging

Apr 22, 2026 globenewswire.com

Neurona Presents Updated Data from Ongoing Clinical Trials of Rezanecel (NRTX-1001) Regenerative Cell Therapy in Mesial Temporal Lobe Epilepsy at 2026 American Academy of Neurology (AAN) Annual Meeting

Background Measuring Aging

Apr 22, 2026 globenewswire.com

Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701

Background Treatments & Drugs

Apr 22, 2026 globenewswire.com

Cloudbreak Pharma Announces Presentation on its Multi-Kinase Inhibition (MKI) Platform and Ongoing Clinical Programs at Eyecelerator @ ARVO 2026

Background Industry & Access

Apr 22, 2026 globenewswire.com

CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies

Background Measuring Aging

Apr 22, 2026 globenewswire.com

Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology

Background Treatments & Drugs

Apr 22, 2026 globenewswire.com

Blue Mountain übernimmt CompuCal, um seine Präsenz in Europa weiter auszubauen und seine Kalibrierungskompetenz gezielt zu stärken

Background Industry & Access

Apr 22, 2026 globenewswire.com

Blue Mountain Acquires CompuCal to Expand European Presence and Deepen Calibration Expertise

Background Industry & Access

Apr 22, 2026 globenewswire.com

Blue Mountain acquiert CompuCal pour renforcer sa présence européenne et son expertise en étalonnage

Background Industry & Access

Apr 22, 2026 globenewswire.com

AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder

Background Treatments & Drugs

Apr 22, 2026 longevity.technology

Medicines360 and Pharma Dynamics announce the launch of Avibela® in South Africa, Expanding Access to Long‑Acting Contraception and Treatment of Heavy Menstrual Bleeding

Background Industry & Access

Apr 22, 2026 globenewswire.com

Axomove lève 4 M€ pour accélérer la commercialisation de son dispositif médical numérique de prévention et de rééducation

Background Industry & Access

Apr 22, 2026 sciencedaily.com

Two common drugs may reverse fatty liver disease, study finds

Important Treatments & Drugs

Apr 22, 2026 globenewswire.com

Team Elles and Jelenew Partner to Drive Women’s Cycling Community in Loire Atlantique

Background Food & Lifestyle

Apr 22, 2026 academic.oup.com

Effects of VIVIFRAIL intervention on multidimensional frailty in older nursing home residents: a randomised-controlled feasibility study

Important Food & Lifestyle

Apr 22, 2026 academic.oup.com

Dual-threshold plasma Aβ oligomerization for postoperative delirium risk stratification

Important Measuring Aging

Apr 21, 2026 globenewswire.com

Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Background Treatments & Drugs

Apr 21, 2026 globenewswire.com

Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease

Background Industry & Access

Apr 21, 2026 longevity.technology

Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ARIA Trial Results at the 2026 American Society of Clinical Oncology Annual Meeting

Background Science & Tech

Apr 21, 2026 globenewswire.com

Record-Breaking SpringFest 2026 Affirms A4M as the Central Forum for Longevity Medicine

Background Measuring Aging

Apr 21, 2026 globenewswire.com

Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment

Background Industry & Access

Apr 21, 2026 globenewswire.com

Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting

Background Treatments & Drugs

Apr 21, 2026 globenewswire.com

Global Virus Network on Measles Resurgence

Background

Apr 21, 2026 lifespan.io

BioAge Reports Positive Phase 1 Data for BGE-102

Important Measuring Aging

Apr 21, 2026 globenewswire.com

4BIO Capital portfolio company Ray Therapeutics announces upsized and oversubscribed $125 Million Series B financing for vision restoration treatments

Background Science & Tech

Apr 21, 2026 globenewswire.com

ImPact Biotech Announces Upcoming Data Presentations for Padeliporfin VTP at AUA and ASCO 2026

Background Industry & Access

Apr 21, 2026 globenewswire.com

Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting

Background Treatments & Drugs

Apr 21, 2026 globenewswire.com

Concerned About Supporting Erectile Health? Life Extension Launches New Men’s Sexual Health Supplement

Background Food & Lifestyle

Apr 21, 2026 globenewswire.com

ACTG Launches Critical Study Evaluating Hormone Therapy for Women Living with HIV in the Menopause Transition

Background Food & Lifestyle

Apr 21, 2026 globenewswire.com

Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies

Background Treatments & Drugs

Apr 21, 2026 globenewswire.com

Le Gala de la Fondation de l’Hôpital de Lachine recueille 322 115 $ pour transformer les soins de santé dans l’Ouest-de-l’Île

Background

Apr 21, 2026 globenewswire.com

Lachine Hospital Foundation Gala raises $322,115 to transform health care in the West Island

Background Industry & Access

Apr 21, 2026 globenewswire.com

Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment

Background Science & Tech

Apr 21, 2026 globenewswire.com

World’s Fastest HIV Test added to the Together TakeMeHome Program for Free at Home HIV Self-Testing Across the United States

Background

Apr 21, 2026 globenewswire.com

Twentyeight Health Launches First Nationwide All-in-One Virtual Clinic & Personalized Care for Women

Background Treatments & Drugs

Apr 21, 2026 globenewswire.com

New Bay Area Lyme Foundation Study Shows Common FDA-Cleared Lyme Tests Miss 64-78% of Early Cases, Underscores Urgent Need for Improved Diagnostics

Background Food & Lifestyle

Apr 21, 2026 globenewswire.com

Brain Cancer Canada Marks Brain Cancer Awareness Month in May with National Landmark Lightings, Community Events, New Research Investments, and a Call to Action

Background Industry & Access

Apr 21, 2026 globenewswire.com

Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors

Background Treatments & Drugs

Apr 21, 2026 globenewswire.com

Medicenna Presents Positive Data Demonstrating Superior Safety and Efficacy Potential of its First-in-Class anti-PD-1 x IL-2 Bifunctional Superkine MDNA113 at AACR 2026

Background Food & Lifestyle

Apr 21, 2026 globenewswire.com

Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting

Background Treatments & Drugs

Apr 21, 2026 globenewswire.com

Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine

Background Industry & Access

Apr 21, 2026 globenewswire.com

Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data

Background Treatments & Drugs

Apr 21, 2026 globenewswire.com

Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveiled at 2026 AACR, Demonstrating Superior Anti-Tumor Activity and Safety

Background Treatments & Drugs

Apr 21, 2026 globenewswire.com

Groundbreaking approaches such as cell therapies on the horizon for transformation of neural hearing loss, Rinri Therapeutics’ review1 shows

Background Measuring Aging

Apr 21, 2026 globenewswire.com

Amphista Therapeutics presents the discovery, characterisation and chemical structure of AMX-883, an orally bioavailable, highly potent and selective DCAF16 degrader of BRD9 at AACR 2026

Background Industry & Access

Apr 21, 2026 sciencedaily.com